Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Brand: Didronel
Etidronate is a bisphosphonate medication primarily used to treat Paget's disease of bone, a condition characterized by excessive bone breakdown and reformation. It acts by inhibiting bone resorption, thereby slowing down the bone remodeling process. Etidronate belongs to the first generation of bisphosphonates and is less potent than newer agents in this class.
For the treatment of Paget's disease of bone, heterotopic ossification, and occasionally osteoporosis.
Outcome:
Reduced etidronate absorption
Mechanism:
Chelation
Outcome:
Increased risk of gastrointestinal irritation
Mechanism:
Additive effect
Outcome:
Reduced etidronate absorption
Mechanism:
Binding
Most likely new formulation: extended-release oral formulation (2025, 30% confidence)
Based on current usage trends and emerging therapies, there is a low (5%) likelihood of significant regulatory changes for etidronate in the next 5 years.
Bisphosphonate
Bisphosphonate